Nanjing, China

Lingxiang Rao

This inventor holds 1 USPTO granted patent. Top assignee: Medichem, S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lingxiang Rao. Retrieved from https://idiyas.com/inventor/lingxiang-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lingxiang Rao: Innovator in Pharmaceutical Standards

Introduction

Lingxiang Rao is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of reference standards and markers for dabigatran etexilate.

Latest Patents

Lingxiang Rao holds a patent for "Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers." This invention relates to dabigatran etexilate and its related substances, providing processes for detecting these substances in samples and analyzing their purity. The patent also includes methods for preparing dabigatran etexilate and pharmaceutical compositions containing it. He has 1 patent to his name.

Career Highlights

Lingxiang Rao is currently associated with Medichem, S.A., where he continues to advance his research and development efforts in pharmaceuticals. His work focuses on enhancing the quality and reliability of pharmaceutical products.

Collaborations

He has collaborated with notable colleagues, including Judit Serra Miralles and Ernesto Durán López, contributing to a dynamic research environment.

Conclusion

Lingxiang Rao's innovative work in the pharmaceutical industry highlights the importance of developing reliable reference standards and markers. His contributions are vital for ensuring the quality and efficacy of pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…